COMMUNIQUÉS West-GlobeNewswire

Change to the Executive Leadership Team
08/08/2019
Please read the full announcement in PDF Attachment 2019_28_Change_to_the_Executive_Leadership_Team_EN
Interim report for the first half of 2019
08/08/2019
Read the full announcement in PDF Attachment 2019_27_Q22019_CompanyAnnouncement_FINAL_EN
Mesa Laboratories, Inc. Announces Pricing of Public Offerings of Common Stock and Convertible Senior Notes
08/08/2019
Source: Mesa Laboratories, Inc. – August 7, 2019 11:20 PM ET Lakewood, Colo., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ: MLAB) (“Mesa”) today announced the pricing of concurrent underwritten [...]
Telix Pharmaceuticals and GenesisCare Commence ENHANCING Prostate Cancer Clinical Study
08/08/2019
MELBOURNE, Australia and SYDNEY, Australia, Aug. 08, 2019 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on developing targeted [...]
Helix Biopharma Corp. Receives U.S. FDA Approval for Phase Ib/II Pancreatic Trial
08/08/2019
RICHMOND HILL, Ontario, Aug. 07, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP), (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment [...]
MyDx Announces Letter to Shareholders
08/08/2019
SAN DIEGO, Aug. 07, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- MyDx, Inc. ( OTC: MYDX ), a leader in science based cannabis health technologies, today issued a press release with the following letter to shareholders. [...]
New England Journal of Medicine Publishes Results from Pivotal Study of WAYLIVRA® (volanesorsen) in Patients with Familial Chylomicronemia Syndrome
07/08/2019
Mean triglyceride levels decreased 77% in volanesorsen-treated patients versus an 18% increase in patients in placebo group Akcea launching WAYLIVRA in the European Union BOSTON and CARLSBAD, Calif, Aug. 07, 2019 (GLOBE [...]
LHC Group Announces Second Quarter 2019 Financial Results
07/08/2019
Strong Execution on Organic Growth and M&A Strategy Affirms 2019 Guidance LAFAYETTE, La., Aug. 07, 2019 (GLOBE NEWSWIRE) -- LHC Group, Inc. (NASDAQ: LHCG) announced its financial results for the quarter ended June [...]
Jean-Denis Talon Retires From Theratechnologies’ Board of Directors
07/08/2019
MONTREAL, Aug. 07, 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) today announced that Mr. Jean-Denis Talon has decided to retire from the board of directors of Theratechnologies. He was [...]
Jean-Denis Talon quitte le conseil d’administration de Theratechnologies
07/08/2019
MONTRÉAL, 07 août 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) a annoncé aujourd’hui que M. Jean-Denis Talon a décidé de quitter le conseil d’administration de Theratechnologies. Il [...]
Atrion Reports Second Quarter Results
07/08/2019
ALLEN, Texas, Aug. 07, 2019 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced that for the second quarter ended June 30, 2019 revenues totaled $40.1 million compared with $38.8 million for the same [...]
OrthoPediatrics Corp. Reports Second Quarter 2019 Financial Results
07/08/2019
Record revenue of $18.2 Million, Up 20.7% Year-over-Year WARSAW, Ind., Aug. 07, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ:KIDS), a company focused exclusively on advancing the field of [...]
Stemline Therapeutics Announces Proposed Public Offering of Common Stock
07/08/2019
NEW YORK, Aug. 07, 2019 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML) , a commercial -stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing innovative oncology [...]
Catalyst Pharmaceuticals Announces Second Quarter 2019 Financial Results and Provides Corporate Update
07/08/2019
Firdapse ® Launch Momentum Continues with Second Quarter Net Revenues of $28.8 Million 409 Adult LEMS Patients Active on Firdapse as of June 30, 2019 Company to Host Quarterly Conference Call at 8:30 am ET Tomorrow [...]
Y-mAbs to Announce Second Quarter 2019 Financial and Operating Results on August 14
07/08/2019
NEW YORK, Aug. 07, 2019 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) today announced that it will report its second quarter 2019 financial and operating results on Wednesday, [...]
The Cooper Companies to Participate in the Wells Fargo Securities Healthcare Conference
07/08/2019
PLEASANTON, Calif., Aug. 07, 2019 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO) will participate in the 2019 Wells Fargo Securities Healthcare Conference in Boston, MA, on September 5, 2019. Albert G. White [...]
Dynavax Technologies Announces Proposed Public Offering of Common Stock, Non-Voting Preferred Stock and Warrants to Purchase Common Stock
07/08/2019
EMERYVILLE, Calif., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (Nasdaq: DVAX), a fully-integrated biopharmaceutical company focused on discovering, developing and commercializing novel vaccines, [...]
CytomX Therapeutics Announces Second Quarter 2019 Financial Results and Provides Business Update
07/08/2019
-Company to Host a Conference Call Today, August 7, 2019, at 5:00 p.m. ET / 2:00 p.m. PT- SOUTH SAN FRANCISCO, Calif., Aug. 07, 2019 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage [...]
ChromaDex Receives Positive Opinion on Nicotinamide Riboside as a Novel Food from the World-Leading European Food Safety Authority (EFSA)
07/08/2019
ChromaDex Achieves Milestone for Nicotinamide Riboside in EU Regulatory Process, Advances to European Commission for Review LOS ANGELES, Aug. 07, 2019 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) today announced [...]

Pages